The aim of this study was to evaluate the usefulness of technetium-99m sestamibi scintimammography (SSM) and combined use of SSM and X-ray mammography (MG) in premenopausal patients with small (< or =2 cm) suspicious breast lesions. Eighty-seven premenopausal women (median age 47 years, range 32-52) with breast lesions ranging from 4 to 20 mm in greatest diameter (median 12 mm) and detected by MG, underwent SSM prior to open breast biopsy. A planar camera and single-photon emission tomography (SPET) technique were used in 23 (26.4%) and 64 (73.6%) patients, respectively. At histological examination, 72 (82.8%) breast cancers (pT1a=3, pT1b=27, pT1c=42) and 15 (17.2%) benign masses were found. Sensitivity, specificity, positive predictive val...
The aim of this trial was to evaluate in developing countries from different regions the diagnostic ...
Purpose: The aim of this study was to investigate the value of Tc-99m sestamibi breast scintigraphy ...
Although mammography is well established as a first-line tool for breast cancer screening and detect...
The aim of this study was to compare the results obtained using X-ray mammography (MG) and 99mTc-ses...
Aims: To evaluate the usefulness of 99m-Tc-sestamibi scintimammography (SSM) in the detection of T1-...
The purpose of this study was to analyse whether the use of Tc sestamibi scintimammography improves ...
The combination of breast examination and radiographic mammography (XRMM) are the established method...
In breast cancer, mammography (MG) fails to reveal malignancy in 10% to 15% of patients, and its sen...
Scintimammography using Tc-99m-sestamibi is a noninvasive and painless diagnostic imaging method tha...
Introduction: The aim of this study was to evaluate the usefulness of 99m-Tc-sestamibi scintimammogr...
The goal of our study was to assess the value of both scintimam-mography with 99mTc-sestamibi(SMM) a...
Nucl Med Commun. 1997 Sep;18(9):839-45. 99Tcm-sestamibi scintimammography in patients with suspicio...
Breast carcinoma is the most common neoplasm found among women in the Western world. Mammography (MM...
The aim of this trial was to evaluate in developing countries from different regions the diagnostic ...
The incidence of breast cancer in the elderly is 10 fold higher than in the population younger than ...
The aim of this trial was to evaluate in developing countries from different regions the diagnostic ...
Purpose: The aim of this study was to investigate the value of Tc-99m sestamibi breast scintigraphy ...
Although mammography is well established as a first-line tool for breast cancer screening and detect...
The aim of this study was to compare the results obtained using X-ray mammography (MG) and 99mTc-ses...
Aims: To evaluate the usefulness of 99m-Tc-sestamibi scintimammography (SSM) in the detection of T1-...
The purpose of this study was to analyse whether the use of Tc sestamibi scintimammography improves ...
The combination of breast examination and radiographic mammography (XRMM) are the established method...
In breast cancer, mammography (MG) fails to reveal malignancy in 10% to 15% of patients, and its sen...
Scintimammography using Tc-99m-sestamibi is a noninvasive and painless diagnostic imaging method tha...
Introduction: The aim of this study was to evaluate the usefulness of 99m-Tc-sestamibi scintimammogr...
The goal of our study was to assess the value of both scintimam-mography with 99mTc-sestamibi(SMM) a...
Nucl Med Commun. 1997 Sep;18(9):839-45. 99Tcm-sestamibi scintimammography in patients with suspicio...
Breast carcinoma is the most common neoplasm found among women in the Western world. Mammography (MM...
The aim of this trial was to evaluate in developing countries from different regions the diagnostic ...
The incidence of breast cancer in the elderly is 10 fold higher than in the population younger than ...
The aim of this trial was to evaluate in developing countries from different regions the diagnostic ...
Purpose: The aim of this study was to investigate the value of Tc-99m sestamibi breast scintigraphy ...
Although mammography is well established as a first-line tool for breast cancer screening and detect...